European Neuropsychopharmacology
Volume 20, Issue 6 , Pages 388-397 , June 2010

Previous stress exposure enhances both anxiety-like behaviour and p35 levels in the basolateral amygdala complex: Modulation by midazolam

  • Elena Anahi Bignante

      Affiliations

    • Departamento de Farmacología, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba. IFEC-CONICET, Argentina
    • ,
  • Gabriela Paglini

      Affiliations

    • Instituto de Investigación Médica Mercedes y Martín Ferreyra. INIMEC. CONICET, Argentina
    • ,
  • Victor Alejandro Molina

      Affiliations

    • Departamento de Farmacología, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba. IFEC-CONICET, Argentina
    • Corresponding Author InformationCorresponding author. Haya de la Torre esquina Medina Allende, Ciudad Universitaria, 5000 Córdoba, Argentina. Tel.: +54 351 4334437x2; fax: +54 351 4334420.

Received 23 November 2009 ,Revised 5 February 2010 ,Accepted 10 February 2010.

References 

  1. Adamec RE, Burton P, Shallow T, Budgell J. Unilateral block of NMDA receptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle — effective hemisphere depends on the behavior. Physiol. Behav. 1999;65:739–751
  2. Adamec RE, Blundell J, Burton P. Neural circuit changes mediating lasting brain and behavioral response to predator stress. Neurosci. Biobehav. Rev. 2005;29:1225–1241
  3. Aggleton JP. The contribution of the amygdala to normal and abnormal emotional states. Trends Neurosci. 1993;16:328–333
  4. Albrechet-Souza L, Cristina de Carvalho M, Rodrigues Franci C, Brandão ML. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Horm. Behav. 2007;52:267–273
  5. Belda X, Rotllant D, Fuentes S, Delgado R, Nadal R, Armario A. Exposure to severe stressors causes long-lasting dysregulation of resting and stress-induced activation of the hypothalamic-pituitary-adrenal axis. Ann. N. Y. Acad. Sci. 2008;1148:165–173
  6. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, et al Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature. 2001;410:376–380
  7. Bignante EA, Rodriguez Manzanares PA, Mlewski EC, Bertotto ME, Bussolino DF, Paglini G, et al. Involvement of septal Cdk5 in the emergence of excessive anxiety induced by stress. Eur. Neuropsychopharmacol. 2008;18:578–588
  8. Calfa G, Volosin M, Molina V. Glucocorticoid receptors in lateral septum are involved in the modulation of the emotional sequelae induced by social defeat. Behav. Brain Res. 2006;172:324–332
  9. Calfa G, Bussolino D, Molina VA. Involvement of the lateral septum and the ventral Hippocampus in the emotional sequelae induced by social defeat: Role of glucocorticoid receptors. Behav. Brain Res. 2007;181:23–34
  10. Cancela LM, Volosin M, Molina VA. Chronic stress attenuation of alpha 2-adrenoceptor reactivity is reversed by naltrexone. Pharmacol. Biochem. Behav. 1998;31:33–35
  11. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci. Biobehav. Rev. 2002;26:321–352
  12. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron. 1997;18:29–42
  13. Cheung ZH, Ip NY. The roles of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol. J. 2007;2:949–957
  14. Cruz AP, Frei F, Graeff FG. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 1994;49:171–176
  15. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH. Aberrant cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron. 2003;40:471–483
  16. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 1992;15:353–375
  17. Davis M. Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy. Eur. J. NeuroSci. 2002;16:395–398
  18. Davis M, Whalen PJ. The amygdala: vigilance and emotion. Mol. Psychiatry. 2001;6:13–34
  19. Dhavan R, Tsai LH. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2001;2:749–759
  20. Dityatev AE, Bolshakov VY. Amygdala, long-term potentiation, and fear conditioning. Neuroscientist. 2005;11:75–88
  21. Fendt M, Fanselow MS. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. Rev. 1999;23:743–760
  22. Fischer A, Sananbenesi F, Schrick C, Spiess J, Radulovic J. Cyclin-dependent kinase 5 is required for associative learning. J. Neurosci. 2002;22:3700–3707
  23. Fischer A, Sananbenesi F, Pang PT, Tsai LH. Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron. 2005;48:825–838
  24. Gray JA, McNaughton N. The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-hippocampal System. 2nd ed.. Oxford: Oxford University Press; 2000;
  25. Harada T, Morooka T, Ogawa S, Nishida E. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat. Cell Biol. 2001;3:453–459
  26. Hawasli AH, Bibb JA. Alternative roles for Cdk5 in learning and synaptic plasticity. Biotechnol. J. 2007;2:941–948
  27. Hawasli AH, Benavides DR, Nguyen C, Kansy JW, Hayashi K, Chambon P, et al Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat. Neurosci. 2007;10:880–886
  28. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997;20:78–84
  29. Holland PC, Gallagher M. Amygdala circuitry in attentional and representational processes. Trends Cogn. Sci. 1999;3:65–73
  30. Isoardi NA, Bertotto ME, Martijena ID, Molina VA, Carrer HF. Lack of feedback inhibition on rat basolateral amygdala following stress or withdrawal from sedative-hypnotic drugs. Eur. J. NeuroSci. 2007;26:1036–1044
  31. Korte SM, De Boer SF. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur. J. Pharmacol. 2003;463:163–175
  32. LeDoux JE. Emotion, memory and the brain. Sci. Am. 1994;270:50–57
  33. LeDoux JE. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000;23:155–184
  34. Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, et al. A brain-specific activator of cyclin-dependent kinase 5. Nature. 1994;371:423–426
  35. Li BS, Sun MK, Zhang L, Takahashi S, Ma W, Vinade L, et al. Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc. Natl. Acad. Sci. U. S. A. 2001;98:12742–12747
  36. Martijena ID, Calvo N, Volosin M, Molina VA. Prior exposure to a brief restraint session facilitates the occurrence of fear in response to a conflict situation: behavioral and neurochemical correlates. Brain Res. 1997;752:136–142
  37. Martijena ID, Rodriguez Manzanares PA, Lacerra C, Molina VA. Gabaergic modulation of the stress response in frontal cortex and amygdala. Synapse. 2002;45:86–94
  38. McGaugh JL. Memory — a century of consolidation. Science. 2000;287:248–251
  39. McGaugh JL, Roozendaal B. Role of adrenal stress hormones in forming lasting memories in the brain. Curr. Opin. Neurobiol. 2002;12:205–210
  40. Mitra R, Sapolsky RM. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2008;105:5573–5578
  41. Nguyen MD, Larivière RC, Julien JP. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron. 2001;30:135–147
  42. Nikolic M, Dudek H, Kwon YT, Ramos YF, Tsai LH. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 1996;10:816–825
  43. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna Pant HC, Brady RO, et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. U. S. A. 1996;93:11173–11178
  44. Paglini G, Cáceres A. The role of the Cdk5–p35 kinase in neuronal development. Eur. J. Biochem. 2001;268:1528–1533
  45. Paglini G, Pigino G, Kunda P, Morfini G, Maccioni R, Quiroga S, et al Evidence for the participation of the neuron-specific Cdk5 activator p35 during laminin-enhanced axonal growth. J. Neurosci. 1998;18:9858–9869
  46. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 1999;402:615–622
  47. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. In: Ed. 3. San Diego: Academic Press; 1997;p. 15–31
  48. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 1985;14:149–167
  49. Petrovich GD, Swanson LW. Projections from the lateral part of the central amygdalar nucleus to the postulated fear conditioning circuit. Brain Res. 1997;763:247–254
  50. Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J. Neurosci. 2004;24:3471–3479
  51. Refojo D, Echenique C, Müller MB, Reul JM, Deussing JM, Wurst W, et al Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proc. Natl. Acad. Sci. U. S. A. 2005;102:6183–6188
  52. Rodgers RJ, Cole JC. Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test. Eur. J. Pharmacol. 1994;261:321–325
  53. Rodriguez Manzanares PA, Isoardi NA, Carrer HF, Molina VA. Previous stress facilitates fear memory, attenuates GABAergic inhibition, and increases synaptic plasticity in the rat basolateral amygdala. J. Neurosci. 2005;25:8725–8734
  54. Roozendaal B, McGaugh JL. Glucocorticoid receptor agonist and antagonist administration into the basolateral but not central amygdala modulates memory storage. Neurobiol. Learn. Mem. 1997;67:176–179
  55. Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdala. Nat. Rev. Neurosci. 2009;10:423–433
  56. Sah P, Faber ES, Lopez De Armentia M, Power J. The amygdaloid complex: anatomy and physiology. Physiol. Rev. 2003;83:803–834
  57. Sanders SK, Morzorati SL, Shekhar A. Priming of experimental anxiety by repeated subthreshold GABA blockade in the rat amygdala. Brain Res. 1995;699:250–259
  58. Sandi C, Loscertales M, Guaza C. Experience-dependent facilitating effect of corticosterone on spatial memory formation in the water maze. Eur. J. NeuroSci. 1997;9:637–642
  59. Sawchenko PE, Brown ER, Chan RK, Ericsson A, Li HY, Roland BL, et al. The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog. Brain Res. 1996;107:201–222
  60. Stam R, Bruijnzeel AW, Wiegant VM. Long-lasting stress sensitisation. Eur. J. Pharmacol. 2000;405:217–224
  61. Takagi M, Yamamoto C. The long-lasting inhibition recorded in vitro from the lateral nucleus of the amygdala. Brain Res. 1981;206:474–478
  62. Takahashi S, Ohshima T, Cho A, Sreenath T, Iadarola MJ, Pant HC, et al Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc. Natl. Acad. Sci. U. S. A. 2005;102:1737–1742
  63. Tsai LH, Delalle I, Caviness VS, Chae T, Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature. 1994;371:419–423
  64. Van Nobelen M, Kokkinidis L. Amygdaloid GABA, not glutamate neurotransmission or mRNA transcription controls footshock-associated fear arousal in the acoustic startle paradigm. Neuroscience. 2006;137:707–716
  65. Veselý J, Havlicek L, Strnad M, Blow JJ, Donella-Deana A, Pinna L, et al. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 1994;224:771–786
  66. Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 2002;22:6810–6818
  67. Vyas A, Pillai AG, Chattarji S. Recovery after chronic stress fails to reverse amygdaloid neuronal hypertrophy and enhanced anxiety-like behavior. Neuroscience. 2004;128:667–673
  68. Wei FY, Tomizawa K, Ohshima T, Asada A, Saito T, Nguyen C, et al. Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J. Neurochem. 2005;93:502–512
  69. Wiedenmayer CP. Adaptations or pathologies? Long-term changes in brain and behavior after a single exposure to severe threat. Neurosci. Biobehav. Rev. 2004;28:1–12
  70. Wu LJ, Ko SW, Toyoda H, Zhao MG, Xu H, Vadakkan KI, et al Increased anxiety-like behavior and enhanced synaptic efficacy in the amygdala of GluR5 knockout mice. PLoS ONE. 2007;2:e167

PII: S0924-977X(10)00040-4

doi: 10.1016/j.euroneuro.2010.02.007

European Neuropsychopharmacology
Volume 20, Issue 6 , Pages 388-397 , June 2010

Article Tools

* Image Usage & Resolution